CAMP Q3 2025 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$795,000

Gross Profit

$379,00047.7% margin

Operating Income

-$13M-1655.0% margin

Net Income

-$15M-1899.2% margin

EPS (Diluted)

$-0.55

QoQ Revenue Growth

-46.9%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$984,000

Balance Sheet

Total Assets

$86M

Total Liabilities

$28M

Stockholders' Equity

$59M

Cash & Equivalents

$75M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$795,000	$0	—
Gross Profit	$379,000	$0	—
Operating Income	-$13M	-$14M	+2.7%
Net Income	-$15M	-$13M	-12.0%